04:51 PM EST - Cangene Corp. : said it expects "great longevity" from its bio-defence contracts with the U.S. government to develop drugs to shield against the spread of infectious disease and the threat of terrorists wielding germ weapons. Cangene Corp.
shares T.CNJ are trading up 5 cents at $7.50.
